Oswal Pumps IPO listing: Will it make a bumper debut? Check latest GMP
Oswal Pumps is poised to make its stock market debut on June 20, amid strong anticipation from investors looking for a bumper debut on Dalal Street.The allotment for the initial public offering (IPO) of Oswal Pumps was finalised on June 18, 2025, after attracting substantial interest despite initial slow demand.The IPO of Oswal Pumps was oversubscribed by more than 34 times, indicating strong confidence from investors, especially among Qualified Institutional Buyers (QIBs) and Non-Institutional Investors (NIIs). This response underscores the institutional trust in the company's fundamental strength and its projected long-term growth prospects, even in the face of market volatility.advertisement
The price band for the IPO was fixed between Rs 584 and Rs 614 per share. The minimum lot size was 24 shares. For retail investors, this meant a minimum investment of Rs 14,016 at the lower end of the price band. However, most retail investors prefer bidding at the cut-off price, which required an investment of Rs 14,736."We believe this overwhelming demand was driven by attractive valuation levels, offering reasonable long-term upside potential along with a well-diversified product portfolio across agriculture, industrial, and domestic water solutions. We also see the company's strategic positioning to benefit from ongoing government infrastructure and rural development initiatives, especially those focused on water management and irrigation," said Prashanth Tapse, Senior VP (Research) at Mehta Equities Ltd.Market experts are optimistic about the listing, expecting a gain in the range of 10–15% based on current market sentiment and the strong subscription demand.advertisementThe estimated listing price is Rs 662, factoring in the current Grey Market Premium (GMP). However, the GMP has seen a decline recently, falling from Rs 60 during allotment to Rs 48 as of June 19."Given the strong subscription demand and ongoing market sentiment, we anticipate a decent listing gain in the range of 10–15% for Oswal Pumps debut. The IPO saw significant oversubscription, reflecting confidence in the company's fundamentals and valuation. We view Oswal Pumps as a compelling long-term investment opportunity, well-aligned with the government's continued emphasis on rural electrification and promotion of solar-powered irrigation systems," added Tapse.For investors who have been allotted shares, holding onto the investment is advised due to the strong structural growth prospects in the agriculture and infrastructure sectors. The company is seen as well-positioned to benefit from sectoral growth drivers."For Allotted investors: We advise a HOLD for the long term, as the company is well-positioned to benefit from structural growth drivers in the agri and infrastructure sectors. For Non-allotted investors: Consider accumulating on any dips post-listing, particularly if broader market sentiment causes short-term volatility. The business offers a strong combination of sectoral tailwinds and value-based fundamentals," he advised further.Investors will be keenly watching the debut, hoping for a favourable outcome that aligns with the optimistic projections.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
32 minutes ago
- News18
Indian Hockey Players To Get A Monthly Stipend From Sports Ministry
Last Updated: Indian hockey players selected for national camps will receive a Rs 25,000 monthly allowance. The decision, costing Rs 20 lakh per month, was approved by the sports ministry. For the first time, Indian hockey players selected for the men's and women's national camps will receive a Rs 25,000 monthly out-of-pocket allowance, a decision sanctioned by the sports ministry after consistent requests from the sport's governing body. Eighty players (40 men and 40 women) are set to benefit from this allowance, which is extended to athletes in the developmental group of the Target Olympic Podium Scheme. The decision was made during the Mission Olympic Cell's monthly meeting on Thursday. This allowance will cost the government Rs 20 lakh per month, while core group athletes receive Rs 50,000 per month. 'The allowance was being requested by Hockey India for some time, and we have decided to accept the demand. The players have performed reasonably well, and it is on merit," Sports Minister Mansukh Mandaviya informed reporters in an informal interaction. Hockey India will need to submit a list of players every month to facilitate the disbursement of funds. 'The list will consider form and fitness, and names might change depending on these factors," a sports ministry source explained. Currently, hockey players earn salaries from their respective departments and organisations, although a proposal for a graded contract system by Hockey India has been under consideration for the past few years. Their additional source of income comes from prize money for strong international performances in events like the Olympics and the Asian Games. The men's team has secured two consecutive bronze medals in the 2021 Tokyo Olympics and the subsequent Paris Games last year. The women's team finished fourth in Tokyo but did not qualify for the Paris event. Both teams are currently competing in the FIH Pro League's European leg, where the results have not been particularly encouraging so far. The MOC also approved financial proposals amounting to Rs 4.28 crore during the meeting. A significant portion of the funds — Rs 1.38 crore — will be allocated to tennis players such as Saketh Myneni, Jeevan Nedunchezhiyan, and three women players. 'Several proposals for assistance from para-athletes were also approved. Additionally, a few additions were made to the TOPS developmental group. The core group remains unchanged for now," a Sports Authority of India (SAI) official stated. The ministry has also decided to enhance its talent identification process with an app that will allow talented youngsters to upload their performances for evaluation by regional talent identification panels of the SAI. 'If found promising at first glance, the youngster will be invited to Khelo India Regional Centres where their potential will be assessed. This will broaden our talent identification mechanism, which is currently limited to age group competitions," Mandaviya said. 'It will ensure that we can reach the remotest corners of the country to find promising athletes. This is all part of the National Sports Repository System," he added. With PTI inputs.
Deccan Herald
44 minutes ago
- Deccan Herald
Samsung to launch Galaxy M36 5G next week in India
Thanks to deeper collaboration with Google and Samsung, the Galaxy M36 will support advanced versions of Gemini AI features. It will be priced under Rs 20,000 in India.
India.com
an hour ago
- India.com
Meet woman, daughter of India's richest pharma tycoon, she now leads Rs 3950000000000 company, she is…, her business is…
Vidhi Shanghvi, Sun Pharma Vidhi Shanghvi is daughter of Dilip Shanghvi, a famous Pharma businessman. She is in headlines for her role in Sun Pharma, one of India's biggest pharmaceutical companies. His net worth is around $25 billion and known as India's richest pharma billionaire. He is also among the top 100 richest people in the world. But now, his daughter Vidhi Shanghvi has also started handling his business. Who Is Vidhi Shanghvi? Vidhi Shanghvi is an Executive Director in Sun Pharma. After 13 years of experience, she now leads Sun Pharma's Consumer Healthcare and India Distribution. Sun Pharma was founded by her father, Dilip Shanghvi in 1983. They started making psychiatric drugs and slowly became India's most valuable pharma company, with a market capitalisation of Rs 3.95 lakh crore. Vidhi was recently appointed as Whole-time Director for a five-year term. Vidhi Shanghvi Educational Background Vidhi graduated from the Wharton School at the University of Pennsylvania. In Sun Pharma, she used her education in marketing and consumer healthcare. She began her career at Sun Pharma in 2012 as a Brand Manager in the India Business division. Over the years, she has held several leadership positions. In 2014, she became the Marketing Head for one of the company's Cardiovascular Business Units. She also handled many marketing campaigns. After the merger of Ranbaxy with Sun Pharma, Vidhi Shanghvi became the Business Head of the company's Consumer Healthcare Division. She has played a big role in the growth of the products like Revital H and Volini in retail stores, pharmacies, and online platforms in India. She also has expertise in various fields like marketing, brand building, project and alliance management, and distribution. She is the founder of Mann Talks, a not-for-profit mental health initiative. This platform gives free, holistic mental health solutions to individuals for their mental well-being.
